Searched for
DRUGMAKERS USING AI
From diapers to drugs: How India's global corporate hubs are putting AI to workHeads of several Global Capability Centres (GCCs) told Reuters they are deploying AI across a host of functions - from marketing and conten...- Global firms bring more work in-house at India hubs on AI boostThe shift reflects a structural change in how multinationals use their India operations, moving beyond cost-focused support roles to centre...
- Global firms bring more work in-house at India hubs on AI boostGlobal firms are bringing more work in-house at their India centres. Artificial intelligence is boosting productivity. This reduces relianc...
- Novo Nordisk uses AI to fast-track drug launches, expand India roleNovo Nordisk is leveraging Artificial Intelligence to significantly speed up new drug launches. The company expects to cut down the time to...
- CEOs are getting ruthless about worker performanceCorporate leaders are increasingly prioritizing results over employee comfort, with CEOs like Unilever's Fernando Fernandez demanding "volu...
- Mark Zuckerberg backed-Cellular Intelligence acquires Novo Nordisk's Parkinson's cell therapyLast October, Novo Nordisk had shut down its cell therapy unit as part of a broader restructuring, discontinuing development of the therap...
- Merck to partner with Google Cloud on AI initiativesDrugmaker Merck & Co is joining forces with Google Cloud. They will invest up to one billion dollars over several years. This partnership a...
- Amazon launches AI research tool to speed early-stage drug discoveryAmazon Web Services has launched Amazon Bio Discovery, an AI tool to accelerate drug discovery. Scientists can now generate and evaluate po...
- Indian pharma may take AI pill to cut time and costs in drug R&DIndian pharmaceutical giants Sun Pharma and Glenmark are embracing Artificial Intelligence to speed up new drug creation. This technology p...
- Drugmakers turn to AI to speed trials, regulatory submissionsAI is helping find participants and sites for clinical trials and drafting documents for regulators, shaving weeks off these labor-intensi...
- Bristol Myers partners with Microsoft for AI-driven lung cancer detectionBristol Myers Squibb is joining forces with Microsoft. They will use artificial intelligence to find lung cancer earlier. This technology a...
- US, European regulators set principles for 'good AI practice' in drug developmentThe principles, issued on Wednesday, offer broad guidance on how AI should be used to generate and monitor evidence across a drug's lifecyc...
- Nvidia, Eli Lilly to spend $1 billion over five years on joint research labNvidia and US pharma giant Eli Lilly will spend $1 billion building a new joint research lab in the San Francisco Bay area over five years...
- Wegovy maker Novo Nordisk bets big on talent, AI partnerships in IndiaNovo Nordisk is broadening its Bengaluru operations by increasing senior leadership, doubling global process leaders in India, and boosting...
- AI startup EvolutionaryScale raises $142 million to advance tech in biologyCalling it a "ChatGPT moment for biology," Lux Capital cofounder and managing partner Josh Wolfe told the company has developed the first l...
- Healthtech company Qure.ai to hit fund trailMumbai-based healthtech firm Qure.ai is preparing for a significant fundraising round early next year to support both organic business expa...
- Nvidia deepens bets on AI in drug discovery with Recursion investmentRecursion, whose advisers include AI pioneer Yoshua Bengio, will use its biological and chemical datasets exceeding 23,000 terabytes to tra...
- Nvidia invests $50 million in Recursion to train AI models for drug discoveryRecursion will train AI models on Nvidia's cloud platform using its own biological and chemical datasets exceeding 23,000 terabytes.
- AI startup Unlearn raises $15 million in funding, adds OpenAI CTO Mira Murati to boardMira Murati, chief technology officer at Microsoft-backed OpenAI, is joining the startup's board.
- What ails India's pharmaceutical sector?Unlike mature markets such as the US, where drug prices are market-controlled, here, the government and regulators play a pivotal role in t...
Load More
